Literature DB >> 22304573

Variation at GLCCI1 and FCER2: one step closer to personalized asthma treatment.

Anke Hilse Maitland-van der Zee, Jan Am Raaijmakers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22304573     DOI： 10.2217/pgs.11.177

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  6 in total

1.  Clinically relevant pharmacogenomic testing in pediatric practice.

Authors:  Lindsey Korbel; Mathew George; Joseph Kitzmiller
Journal:  Clin Pediatr (Phila)       Date:  2014-05-06       Impact factor: 1.168

2.  Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids.

Authors:  Renata Szalai; Petra Matyas; Dalma Varszegi; Marton Melegh; Lili Magyari; Luca Jaromi; Katalin Sumegi; Balazs Duga; Erzsebet Kovesdi; Kinga Hadzsiev; Bela Melegh
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

3.  GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma.

Authors:  Louise Hosking; Eugene Bleecker; Soumitra Ghosh; Astrid Yeo; Loretta Jacques; Michael Mosteller; Deborah Meyers
Journal:  J Allergy Clin Immunol       Date:  2013-10-13       Impact factor: 10.793

4.  Glucocorticoid-Induced Transcription Factor 1 (GLCCI1) Variant Impacts the Short-Term Response to Intranasal Corticosteroids in Chinese Han Patients with Seasonal Allergic Rhinitis.

Authors:  Yuyang Dai; Siyang Ni; Feng Wu; Xiuli Zhao
Journal:  Med Sci Monit       Date:  2018-07-07

5.  Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.

Authors:  Qing Kong; Yuxue Cao; Zhen Gao; Jing Sun; Hongying Zhang; Yijie Du; Yubao Lv; Sihan Zhou; Zihui Tang; Baojun Liu; Jingcheng Dong
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.279

6.  GLCCI1 rs37973: A potential genetic predictor of therapeutic response to inhaled corticosteroids in Chinese asthma patients.

Authors:  Yuzhu Xu; Hongxu Wu; Xiaojie Wu; Yongjian Xu; Jianping Zhao; Jungang Xie; Jun Yu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.